Awareness, perceptions and attitudes toward medication-related osteonecrosis of the jaw among physicians who treat osteoporosis
Osteoporosis is the most common indication for antiresorptive drugs (ARDs). Medication-related osteonecrosis of the jaw (MRONJ) is a severe complication of ARDs. Multiple risk factors can increase the risk of MRONJ, one of which is the duration of ARD intake, which is usually prolonged for osteoporo...
Saved in:
Main Author: | Suad Aljohani (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Knowledge, attitude, and management of general dentist toward medication-related osteonecrosis of the jaws
by: Nasser R Alqhtani, et al.
Published: (2020) -
Medication-related osteonecrosis of the jaw
by: Heliton Spindola Antunes, et al.
Published: (2018) -
Dose-Intensity of Bisphosphonates and the Risk of Osteonecrosis of the Jaw in Osteoporosis Patients
by: Sung-mok Jung, et al.
Published: (2018) -
Skin involvement of medication-related osteonecrosis of jaws in an immunocompromised, bisphosphonate-treated patient
by: Ye Eun Kim, MD, et al.
Published: (2022) -
The biological mechanisms of the antiresorptive therapy of osteoporosis, and the antiresorptive drug related osteonecrosis of jaws
by: István Gera, et al.
Published: (2024)